Cornea 2021 Apr;40(4):449-452
*F. I. Proctor Foundation, University of California, San Francisco, CA; †Casey Eye Institute, Oregon Health Sciences University, Portland, OR; ‡Byers Eye Institute, Stanford University, Palo Alto, CA; §Lions VisionGift, Portland, OR; ¶Department of Ophthalmology, University of California, San Francisco, CA; ‖Department of Epidemiology and Biostatistics, University of California, San Francisco, CA; and **Department of Research, Kaiser Permanente Northern California.
Purpose: To determine which baseline characteristics are associated with vision-related quality of life (QOL) after endothelial keratoplasty.
Methods: A patient- and outcome-masked randomized clinical trial. Consecutive patients presenting with isolated endothelial disease requiring endothelial keratoplasty at Oregon Health Sciences University and Stanford University. Read More